These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 25156438

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effectiveness of sulodexide might be associated with inhibition of complement system in hepatitis B virus-associated membranous nephropathy: An inspiration from a pilot trial.
    Yang Y, Ma L, Wang C, Kong D, Wang Y, Mei C.
    Eur J Intern Med; 2016 Jul; 32():96-104. PubMed ID: 27160380
    [Abstract] [Full Text] [Related]

  • 4. Successful Use of Entecavir in Hepatitis B-associated Membranous Nephropathy.
    Mahajan V, D'Cruz S, Nada R, Sachdev A.
    J Trop Pediatr; 2018 Jun 01; 64(3):249-252. PubMed ID: 28977667
    [Abstract] [Full Text] [Related]

  • 5. Long-term lamivudine therapy in hepatitis B-associated membranous nephropathy?
    Ng YY, Yang WC, Lee ST.
    Kidney Int; 2006 Feb 01; 69(4):776. PubMed ID: 16518335
    [No Abstract] [Full Text] [Related]

  • 6. Successful treatment of occult hepatitis B virus infection related membranous nephropathy after entecavir therapy.
    Xiong QF, Zhong YD, Hu ZL, Yang YF.
    Acta Clin Belg; 2015 Jun 01; 70(3):223-5. PubMed ID: 25510219
    [Abstract] [Full Text] [Related]

  • 7. Hepatitis B-related membranous nephropathy should be treated with a specific anti-viral agent.
    Tang S, Lai KN.
    Kidney Int; 2006 Aug 01; 70(4):818. PubMed ID: 16900222
    [No Abstract] [Full Text] [Related]

  • 8. [New advances in the treatment of chronic hepatitis B: position of entecavir].
    Olaso V.
    Rev Esp Quimioter; 2007 Sep 01; 20(3):259-60. PubMed ID: 18080023
    [No Abstract] [Full Text] [Related]

  • 9. A Meta-Analysis of Antiviral Therapy for Hepatitis B Virus-Associated Membranous Nephropathy.
    Yang Y, Ma YP, Chen DP, Zhuo L, Li WG.
    PLoS One; 2016 Sep 01; 11(9):e0160437. PubMed ID: 27598699
    [Abstract] [Full Text] [Related]

  • 10. Complete remission of hepatitis B virus-related membranous nephropathy after entecavir monotherapy.
    Yang YF, Xiong QF, Zhao W, Zhong YD.
    Clin Res Hepatol Gastroenterol; 2012 Oct 01; 36(5):e89-92. PubMed ID: 22572521
    [Abstract] [Full Text] [Related]

  • 11. Entecavir is an optional agent to prevent hepatitis B virus (HBV) reactivation: a review of 16 patients.
    Watanabe M, Shibuya A, Takada J, Tanaka Y, Okuwaki Y, Minamino T, Hidaka H, Nakazawa T, Koizumi W.
    Eur J Intern Med; 2010 Aug 01; 21(4):333-7. PubMed ID: 20603047
    [Abstract] [Full Text] [Related]

  • 12. Use of entecavir for the treatment of complex forms of hepatitis B.
    Sacco R.
    Eur Rev Med Pharmacol Sci; 2014 Aug 01; 18(9):1333-43. PubMed ID: 24867511
    [Abstract] [Full Text] [Related]

  • 13. Successful Management of De Novo Acute Hepatitis B Virus Infection With Entecavir in a Living-Donor Liver Transplant Patient.
    Akbulut S, Harputluoglu M, Yilmaz S.
    Exp Clin Transplant; 2018 Oct 01; 16(5):635-637. PubMed ID: 29790455
    [Abstract] [Full Text] [Related]

  • 14. [Anti-hepatitis B virus drugs].
    Minami M.
    Nihon Rinsho; 2012 Apr 01; 70(4):609-13. PubMed ID: 22568141
    [Abstract] [Full Text] [Related]

  • 15. Treatment of hepatitis B virus-associated nephropathy.
    Elewa U, Sandri AM, Kim WR, Fervenza FC.
    Nephron Clin Pract; 2011 Apr 01; 119(1):c41-9; discussion c49. PubMed ID: 21677438
    [Abstract] [Full Text] [Related]

  • 16. American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.
    Reddy KR, Beavers KL, Hammond SP, Lim JK, Falck-Ytter YT, American Gastroenterological Association Institute.
    Gastroenterology; 2015 Jan 01; 148(1):215-9; quiz e16-7. PubMed ID: 25447850
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.